Quest Diagnostics to Host Investor Day on March 19, 2025
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) has announced plans to host an Investor Day event on March 19, 2025 at the New York Stock Exchange. The event will feature presentations from key executives including Chairman, CEO and President Jim Davis, and Executive Vice President and CFO Sam Samad.
The leadership team will provide institutional investors and financial analysts with insights into several key areas including:
- Updated perspectives on the U.S. laboratory market
- Company's business strategy
- Capital deployment priorities
- Long-term outlook
The event requires advance registration and will be accessible via live webcast on Quest Diagnostics' Investor Relations website. An archived version of the webcast will be made available following the event's conclusion.
Details
News Market Reaction – DGX
The recorded move for DGX in the trading session of this news was +0.03%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
During the event, Jim Davis, Chairman, CEO and President, Sam Samad, Executive Vice President and CFO, and other senior executives will provide updated views of the
To register for the event, please go to: Quest Diagnostics 2025 Investor Day Registration.
A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website.
An archived copy of the webcast will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-19-2025-302376570.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.